Internet-Based Drug Prevention Education for College Students

描述（由申请人提供）：本申请建议为大学生开发和测试一个交互式的在线药物使用预防程序，MyStudentBody-Drugs （MSB-Drugs）。面向一级和二级预防，MSB-Drugs将促进预防的动机，开始或减少药物使用和相关的风险行为。与酒精相比，校园里的预防吸毒被忽视了，尽管吸毒很普遍，后果也很严重。大麻是使用最广泛的非法药物，其次是非医疗用途的处方药，包括兴奋剂（右苯丙胺、哌甲酯）和阿片类药物（羟考酮、氢可酮）。2003年，大约有10%的高中毕业生报告说他们使用氢可酮非医疗用途，这使得氢可酮成为这个群体第三大滥用药物，仅次于大麻和安非他明。从2002年到2003年，大学生中滥用羟考酮的人数增加了近40%。将处方药与其他药物（如酒精）混合，会进一步增加药物相互作用和过量服用的风险。公共卫生需要为大学生提供容易获得和有效的毒品预防，这是显而易见的。最近NIDA的举措认识到了这一需求（处方药滥用，PA-01-110; Volkow, 2005）。MSB-Drugs将利用技术和富媒体整合关键的循证预防功能，包括提供量身定制反馈的个人风险评估，以促进动机，关于不同药物和成瘾的相关教育，以促进准确的风险评估，以及技能建设活动，以提高拒绝和应对技能以及自我效能感。第一阶段涉及概念验证研究，以证明产品的可行性。第二阶段将包括一个全面运作的MSB-Drugs网站的制作和可用性测试，以及一项随机对照试验，以评估项目对影响药物相关知识、态度和行为的有效性。

DESCRIPTION (provided by applicant): This application proposes development and testing of an interactive, online drug use prevention program for college students, MyStudentBody-Drugs (MSB-Drugs). Geared toward primary and secondary prevention, MSB-Drugs will promote motivation to prevention initiation of, or reduce, drug use and associated risk behaviors. Compared to alcohol, drug use prevention is neglected on campuses, despite the prevalence of use and significant consequences. Marijuana is the most widely used illicit drug, followed by non-medical use of prescription drugs, including stimulants (dextroamphetamine, methyphenidate) and opioids (oxycodone, hydrocodone). In 2003, roughly 10 percent of high school seniors reported non- medical use of hydrocodone, making it the third most abused substance for this group, after marijuana and amphetamines. From 2002 to 2003, abuse of oxycodone increased by nearly 40 percent among college- aged youth. Mixing prescription drugs with other drugs, such as alcohol, further increases risk for drug interactions and overdose. The public health need for easily accessible and effective drug prevention for college students is clear. Recent NIDA initiatives recognize this need (Prescription Drug Abuse, PA-01-110; Volkow, 2005). MSB-Drugs will use technology and rich media to incorporate key evidence-based prevention features, including personal risk assessments with tailored feedback to promote motivation, relevant education about different drugs and addiction to foster accurate risk appraisals, and skill-building activities to promote refusal and coping skills and self-efficacy. Phase I involved proof of concept research to demonstrate product feasibility. Phase II will involve production and usability testing of a fully operational MSB-Drugs website, and a randomized, controlled trial to assess program efficacy for influencing drug- related knowledge, attitudes, and behaviors.